Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

These tumors are fast growing and tend to spread through the cerebrospinal fluid, mostly to the spinal cord. The 5-year survival rate for medulloblastoma is about 70%. But for the around 30% of ...